Antipsychotic Medicine Manufacturers in India

Antipsychotic Medicine Manufacturers in India

Antipsychotic Medicine Manufacturers in India – Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder, and others. The global antipsychotic drug market size was valued at USD 11.7 billion in 2015 and is expected to grow at a CAGR of 2.1% over the forecast period. Listed below are the leading Antipsychotic Medicine Manufacturers in India.

Antipsychotic Medicine Manufacturers in India

The growing prevalence of psychosis and related diseases is driving the demand for antipsychotic drugs. The major factors contributing to the growing incidence of these disorders include genetic mutations, substance-induced psychoses, and physical illness resulting in depression. In addition, increasing efforts taken by the market players to expand therapeutic applications of these medicines are anticipated to create opportunities for the expansion of the portfolio of antipsychotics in the near future, thereby fueling the demand.

The patent expirations of key brands, such as Seroquel, Risperdal, Zyprexa, and Invega are restraining the growth of these brands. Moreover, players are introducing generic versions of antipsychotics and have begun investigating new therapeutic applications for these products; hence the generic products are slowly replacing the established brands in the antipsychotic market.

List of Top Antipsychotic Medicine Manufacturers in India

The key players within the global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this market. 

Listed in this article are some of the leading Antipsychotic Medicine Manufacturers in India. We have also provided the details of their company and product range for your help. Choose accordingly.

1. Flagship Biotech International Pvt. Ltd

Flagship Biotech International Pvt. Ltd established in the year 2009. The company is one of the fastest-growing India’s leading Generic and Specialty Pharmaceutical companies engaged in Developing, Manufacturing, and Marketing a broad range of Pharmaceutical Formulations. Their state of the Art Manufacturing Facilities maintaining high-Quality standards at every further stage in the manufacturing process are located in Tarapur near Mumbai (Maharashtra, India) Navsari, Naroda (Gujrat, India), Baddi (Himachal Pradesh, India).

Flagship Biotech International Pvt. Ltd. is a renowned manufacturer of antipsychotic products as well as a vast range of generic products and branded pharmaceutical formulations in almost any form. As a company, it is committed to affordable health care. With a presence in more than 45 countries it has more than 400+ registered formulations under its brand. Their company is known for its wide range of 1000+ pharma products and medicines. The product list includes:

  • Piracetam Injection
  • Haloperidol Decanoate Injection
  • Zuclopenthixol Decanoate Injection BP
  • Zuclopenthixol Acetate Injection BP
  • Flupentixol Injection BP
  • Valproate Sodium Injection USP
  • Levetiracetam Injection USP
  • Edaravone Injection JP
  • Phenytoin Injection BP
  • Vasopressin Injection USP

Contact them – 1204 & 1302, Rupa Solitaire, Plot No A-1, Sector – 1, MBP, T.T.C. Indl, Mahape, Navi Mumbai-400701

2. Swiss Pharma Pvt. Ltd.:

Swiss Pharma Pvt. Ltd. established in the year 1958. They are manufacturers of many pharmaceutical finished products like tablets, capsules, dry powders, liquid orals, and sterile products for parenteral and ophthalmic use. They are manufacturer and exporter of Antipsychotics Medicines tablets & capsules in Ahmedabad, Gujarat India.

Their highly qualified team and efforts have lead us to obtain WHO-GMP certification and ISO certification. Their confidence in the products they provide is due to their one hundred percent efforts in the QUALITY of these products. They strictly follow the cGMP, cGLP, and cGMP guidelines. Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia, or disordered thought), principally in schizophrenia and bipolar disorder. The product list includes:

  • ALPRAZOLAM TABLETS
  • AMITRIPTYLINE HCL TABLETS
  • AMITRIPTYLINE HCL & CHLORDIAZEPOXIDE TABLETS
  • ARIPIPRAZOLE TABLETS
  • BETAHISTINE HCL TABLETS
  • BUPROPION HYDROCHLORIDE SR TABLETS
  • BUSPIRONE HCL TABLETS
  • CARBAMAZEPINE TABLETS
  • CHLORDIAZEPOXIDE TABLETS
  • CHLORPROMAZINE HCL TABLETS
  • CITALOPRAM TABLETS
  • CLOBAZAM TABLETS
  • CLOMIPRAMINE HCL TABLETS
  • CLONAZEPAM TABLETS
  • CLOZAPINE TABLETS
  • DESVENLAFAXINE EXTENDED-RELEASE TABLETS
  • DIAZEPAM TABLETS
  • DIVALPROEX SODIUM DELAYED RELEASE TABLETS
  • DOTHIEPIN HCL TABLETS
  • DOXEPIN HCL CAPSULES
  • DULOXETINE DELAYED RELEASE CAPSULES / TABLETS
  • ESCITALOPRAM TABLETS
  • FLUNARIZINE HCL TABLETS
  • FLUOXETINE CAPSULES
  • GABAPENTIN CAPSULES
  • HELOPERIDOL & TRIHEXYPHENIDYL TABLETS
  • HELOPERIDOL TABLETS
  • IMIPRAMINE & DIAZEPAM TABLETS
  • IMIPRAMINE HCL TABLETS
  • LORAZEPAM TABLETS
  • NITRAZEPAM TABLETS
  • NORTRIPTYLINE TABLETS
  • OLANZAPINE TABLETS
  • PAROXETINE CONTROL RELEASE TABLETS
  • PHENYTOIN SODIUM CAPSULES / TABLETS
  • PIRACETAM TABLETS
  • PREGABALIN & METHYLCOBALAMIN CAPSULES
  • PREGABALIN CAPSULE
  • PROCHLORPARAZINE MALEATE TABLETS
  • QUETIAPINE TABLETS
  • RISPERIDONE TABLETS
  • SERTRALINE TABLETS
  • THIORIDAZINE TABLETS
  • TOPIRAMATE TABLETS
  • TRIFLUOPERAZINE TABLETS
  • TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS
  • VENLAFAXINE TABLETS
  • ZOLPIDEM TABLETS

Contact them – Swiss Pharma Pvt. Ltd. 3709, G.I.D.C., Phase IV, Vatva, Ahmedabad – 382 445 Gujarat. India.

3. Kivonyx Healthcare:

Kivonyx Healthcare established in the year 2017. The company is a division of Octavius Pharma Pvt. Ltd. focused on the domestic (Indian) market. They always provide the highest quality medicine for their customers and they have greatly promoted the culture of WHO GMP throughout the company. They are looking to expand our reach throughout India by continuously adding new distributors and agents by offering Pharma Franchise/PCD model in various states for our pharmaceutical products.

The company is using world-class manufacturing facilities at Gujarat and Himachal Pradesh for the manufacturing of their products. Kivonyx Healthcare is all set to meet the upcoming challenges in the field of healthcare. A highly qualified and devoted workforce has always been an asset to the company. They are highly appreciated by clients for offering excellent quality products. With their team’s support, they have been able to cater to the varied needs of patrons in an efficient manner.

They manufacture high quality of Antipsychotic Medicine known as Olanzapine 20 mg Tablets whose product details include:

  • Strength: 20 mg
  • Location/City: Pan India
  • Brand: Osozap 20
  • Do You Offer Generic Or Brand: Brand
  • Composition: Olanzapine 20 mg
  • Manufacturer: Kivonyx
  • Prescription/Non prescription: Prescription
  • Form: Tablet
  • Usage: Nervous System
  • Promotional Material: Visiting Cards
  • Also gives: PCD Pharma Franchise
  • Type of Product Range: General
  • Number Of Already Existing Franchises: 50
  • Therapeutic Uses: Bipolar Disorder

Contact them – 407-A Primate House Opp Mother Milk Palace, Nr Judges Bungalows, Bodakdev, Ahmedabad-380015, Gujarat, India

Scope of investing in Antipsychotic Medicine market

  • There is an ever-increasing demand or Antipsychotic drugs with greater efficacy and lesser adverse reactions for the treatment of major psychotic disorders including schizophrenia, bipolar disorder, unipolar depression, and other psychotic disorders.
  • Among the disease segments, the largest global market share was attributed to schizophrenia in 2018.
  • The large unmet need for new and advanced treatment options of psychotic disorders, with an aim to reduce the adverse effects of antipsychotic drugs on the individuals and greater awareness, has been instrumental in the development and introduction of antipsychotic drugs.

Conclusion:

Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This translates into a potential market of about 7.5 mn people as target consumers for antipsychotic drugs. Although the potential consumer base for the market is relatively much smaller than that for diseases such as cancer and diabetes, the high costs of antipsychotic drugs make the market one with promising returns.

The market holds immense growth promise for future years as the patient pool of psychotic conditions rises at an alarming rate across the globe. The introduction of newer antipsychotic compounds and the vast funds poured in for research and development activities are also expected to have a significant positive impact on the overall development of the market in the near future.

Choose from the listed Antipsychotic Medicine Manufacturers in India to get better services ad products. For more information contact us.

Contact Us